CAS:81149-12-4|(5’a,10a)-1-Demethyl-9,10-dihydro-12′-hydroxy-2′-methyl-5′-(phenylmethyl)-2,3(2H,3H)-secoergotaman-3,3′,6′,18-tetrone

CAS:81149-12-4|(5’a,10a)-1-Demethyl-9,10-dihydro-12′-hydroxy-2′-methyl-5′-(phenylmethyl)-2,3(2H,3H)-secoergotaman-3,3′,6′,18-tetrone

Catalogue Number:D231050
Chemical Name:(5’a,10a)-1-Demethyl-9,10-dihydro-12′-hydroxy-2′-methyl-5′-(phenylmethyl)-2,3(2H,3H)-secoergotaman-3,3′,6′,18-tetrone
Synonyms:8H-Oxazolo[3,2-a]pyrrolo[2,1-c]pyrazine, 2,3(2H,3H)-secoergotaman-3,3′,6′,18-tetrone deriv.; Benzo[f]quinoline, 2,3(2H,3H)-secoergotaman-3,3′,6′,18-tetrone deriv. (2R,4aR,10bR)-7-Amino-1,2,3,4,4a,5,6,10b-octahydro-4-methyl-N-[(2R,5S,10aS,10bS)-octahydro-10b-hydroxy-2-methyl-3,6-dioxo-5-(phenylmethyl)-8H-oxazolo[3,2-a]pyrrolo[2,1-c]pyrazin-2-yl]-6-oxo-benzo[f]quinoline-2-carboxamide
CAS Number:81149-12-4
Molecular Formula:C₃₂H₃₇N₅O₆
Appearance:Pale Yellow to Light Brown Solid
Melting Point:>165°C (dec.)
Molecular Weight:587.67
Storage:- 86°C
Solubility:Chloroform (Slightly), Methanol (Slightly)
Stability
Temperature Sensitive
Category:Standards; Pharmaceutical/API Drug Impurities/Metabolites;
Applications:(5’a,10a)-1-Demethyl-9,10-dihydro-12′-hydroxy-2′-methyl-5′-(phenylmethyl)-2,3(2H,3H)-secoergotaman-3,3′,6′,18-tetrone is a derivative of dihydroergotamine (D449080), a ergot alkaloid used to treat migraines.
References:Stadler, P.A., et al.: Euro. J. Med. Chem., 16, 349 (1981);
To ensure the stability of our products, the efficient express delivery service will be used. We also guarantee that the products will be shipped in the box with layers of tapes to protect them against damage. The extremely low temperature products will be wrapped with dried ice, and the low temperature products will be delivered with ice bags. As for the products stored at room temperature, they will not be packed with ice bags or dried ice. Taskcm is committed to providing cost-effective products that facilitate drug delivery with our customers.
Email:sales@ebclink.com

Comments

No comments yet. Why don’t you start the discussion?

Leave a Reply

Your email address will not be published. Required fields are marked *